|
Cerdido S, Abrisqueta M, Sanchez-Beltran J, Lambertos A, Castejon-Grinan M, Munoz C, Olivares C, Garcia-Borron JC, Jimenez-Cervantes C, Herraiz C. MGRN1 depletion promotes intercellular adhesion in melanoma by upregulation of E-cadherin and inhibition of CDC42. Cancer Lett. 2024 Jan 28;581:216484. doi: 10.1016/j.canlet.2023.216484. Epub 2023 Nov 25. PubMed PMID: 38008393.
AÑO: 2024; IF: 9.1
|
38008393
|
Castejon-Grinan M, Cerdido S, Sanchez-Beltran J, Lambertos A, Abrisqueta M, Herraiz C, Jimenez-Cervantes C, Garcia-Borron JC. Melanoma-associated melanocortin 1 receptor variants confer redox signaling-dependent protection against oxidative DNA damage. Redox Biol. 2024 Jun;72:103135. doi: 10.1016/j.redox.2024.103135. Epub 2024 Mar 26. PubMed PMID: 38565069; PubMed Central PMCID: PMC11002308.
AÑO: 2024; IF: 10.7
|
|
Abrisqueta M, Cerdido S, Sanchez-Beltran J, Martinez-Vicente I, Herraiz C, Lambertos A, Olivares C, Sevilla A, Alonso S, Boyano MD, Garcia-Borron JC, Jimenez-Cervantes C. MGRN1 as a Phenotypic Determinant of Human Melanoma Cells and a Potential Biomarker. Life (Basel). 2022 Jul 26;12(8):1118. doi: 10.3390/life12081118. PubMed PMID: 35892921; PubMed Central PMCID: PMC9331370.
AÑO: 2022; IF: 3.251
|
|
Herraiz C, Martinez-Vicente I, Maresca V. The alpha-melanocyte-stimulating hormone/melanocortin-1 receptor interaction: A driver of pleiotropic effects beyond pigmentation. Pigment Cell Melanoma Res. 2021 Jul;34(4):748-761. doi: 10.1111/pcmr.12980. Epub 2021 May 2. PubMed PMID: 33884776.
AÑO: 2021; IF: 4.159
|
|
Martinez-Vicente I, Abrisqueta M, Herraiz C, Jimenez-Cervantes C, Garcia-Borron JC, Olivares C. Functional characterization of a C-terminal splice variant of the human melanocortin 1 receptor. Exp Dermatol. 2020 Jul;29(7):610-615. doi: 10.1111/exd.14118. Epub 2020 Jun 15. PubMed PMID: 32474972.
AÑO: 2020; IF: 3.96
|